Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
12 studies found for:    Open Studies | Interventional Studies | cancer | green tea
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Recruiting Oral Green Tea Extract and Milk Thistle Extract to Colorectal Cancer Patients Undergoing Resection
Condition: Colon Cancer
Intervention: Drug: Green Tea and Milk Thistle Supplements
Study Start: July 2011
Study Completion: July 2018
2 Recruiting Phase I Chemoprevention Trial With Green Tea Polyphenon E & Erlotinib in Patients With Premalignant Lesions of the Head & Neck
Conditions: Cancer of Head and Neck;   Neoplasms, Head and Neck
Interventions: Drug: Erlotinib;   Dietary Supplement: Green Tea Polyphenon E
Study Start: March 2010
Study Completion: March 2019
3 Not yet recruiting Chemopreventive Effects of Epigallocatechin Gallate (EGCG) in Colorectal Cancer (CRC) Patients
Condition: Colon Cancer
Intervention: Dietary Supplement: Epigallocatechin gallate (EGCG)
Study Start: November 2016
Study Completion: November 2019
4 Recruiting Transcutaneous Electrical Acupoint Stimulation for Non-small Cell Lung Cancer Patients
Conditions: Non-Small Cell Lung Cancer;   Lung Cancer
Interventions: Device: TEAS;   Drug: Sanguisorba officinalis L.
Study Start: August 2014
Study Completion: December 2016
5 Recruiting Oral Green Tea Extract for Small Cell Lung Cancer
Condition: Small Cell Lung Carcinoma
Intervention: Dietary Supplement: epigallocatechin gallate
Study Start: May 2011
Study Completion: August 2020
6 Recruiting α-TEA in Advanced Cancer
Conditions: Metastatic Carcinoma;   Metastatic Sarcoma;   Metastatic Lymphoma
Interventions: Drug: 2.4 mg/kg α-TEA;   Drug: 4.8 mg/kg α-TEA;   Drug: 8.0 mg/kg α-TEA;   Drug: 9.6 mg/kg α-TEA;   Drug: 12 mg/kg α-TEA;   Drug: 16.8 mg/kg α-TEA;   Drug: 19.2 mg/kg α-TEA;   Drug: 22.3 mg/kg α-TEA;   Drug: 26.8 mg/kg α-TEA
Study Start: July 2014
Study Completion: July 2021
7 Not yet recruiting Efficiency of Acupuncture-assisted Anesthesia With Single Acupoint or Dual Acupoints in Patients Undergoing Radical Operation of Breast Cancer
Condition: Pain
Interventions: Device: dual acupoints TEAS;   Device: single acupoint TEAS;   Device: false TEAS
Study Start: April 2016
Study Completion: January 2018
8 Recruiting Minimizing the Risk of Metachronous Adenomas of the Colorectum With Green Tea Extract -MIRACLE-
Conditions: Colorectal Serrated Adenomas;   Colorectal Tubular Adenomas;   Colorectal Villous Adenomas;   Colorectal Tubulovillous Adenomas
Interventions: Dietary Supplement: Green tea extract of Camellia Sinensis;   Dietary Supplement: Green tea extract of Camellia Sinensis followed by placebo
Study Start: November 2011
Study Completion: March 2018
9 Not yet recruiting Clear Liquid vs Liberalized Diet in Preparation for Colonoscopy
Condition: Colorectal Cancer
Interventions: Other: Clear Liquid Diet;   Other: Full Liquid Diet
Study Start: January 2016
Study Completion: December 2016
10 Recruiting Clinical Trial on Palliative Cancer Patients With Constipation
Condition: Constipation
Interventions: Drug: Chinese herbal medicine;   Drug: Placebo
Study Start: November 2016
Study Completion: June 2017
11 Recruiting Tumor and Treatments Impact on Neurocognitive Functions and Quality of Life of Patients With OMS Grade II Glioma
Condition: OMS Grade II Glioma
Intervention: Behavioral: neurocognitive tests
Study Start: February 2011
Study Completion: February 2019
12 Recruiting Short-Term Fasting: Impact on Toxicity
Condition: Fasting in Malignant Solid Tumors
Interventions: Other: Short-term fasting;   Other: Modified fast;   Other: Fasting
Study Start: July 9, 2009
Study Completion: July 9, 2019

Study has passed its completion date and status has not been verified in more than two years.